No reason for any company to buy AEGY. Because of the toxic debt, zero inventory and zero proprietary/intellectual property, it's cheaper for any company, including AEGY, to start from scratch with a new company, therefore a new ticker. This leaves shareholders of the once PharmaJanes model, holding the bag.